Gallbladder emptying is an important factor in fragment disappearance after shock wave lithotripsy. 1993

M Sackmann, and H Eder, and U Spengler, and J Pauletzki, and J Holl, and G Paumgartner, and T Sauerbruch
Department of Medicine II, Klinikum Grosshadern, University of Munich, Germany.

The role of gallbladder emptying in fragment disappearance following shock wave lithotripsy of gallstones is poorly understood. We studied gallbladder motility in two groups of patients who had been treated by electrohydraulic shock wave lithotripsy and bile acid dissolution therapy. Group I (n = 20) consisted of patients with fragment disappearance within 18 months after lithotripsy, while patients in group II (n = 20) still harboured fragments in the gallbladder 18 months after lithotripsy. Fasting gallbladder volume was 19 +/- 10 ml (mean +/- S.D.) in group I, and 24 +/- 12 ml in group II (not significant). The residual volume was 8 +/- 9 ml in group I, but 18 +/- 14 ml in group II (p < 0.005). Thus, patients in group I ejected nearly twice as much of the fasting gallbladder volume as patients in group II. This difference in gallbladder emptying was still present if only the patients with single stones were compared in both groups. From the results of this retrospective study we conclude that gallbladder emptying is an important factor for complete fragment disappearance after gallstone disintegration by extracorporeally generated shock waves. Further prospective studies are needed to confirm these observations.

UI MeSH Term Description Entries
D008096 Lithotripsy The destruction of a calculus of the kidney, ureter, bladder, or gallbladder by physical forces, including crushing with a lithotriptor through a catheter. Focused percutaneous ultrasound and focused hydraulic shock waves may be used without surgery. Lithotripsy does not include the dissolving of stones by acids or litholysis. Lithotripsy by laser is LITHOTRIPSY, LASER. ESWL (Extracorporeal Shockwave Lithotripsy),Electrohydraulic Shockwave Lithotripsy,Extracorporeal Shockwave Lithotripsy,Litholapaxy,Noninvasive Litholapaxy,Percutaneous Ultrasonic Lithotripsy,Ultrasonic Lithotripsy,ESWLs (Extracorporeal Shockwave Lithotripsy),Electrohydraulic Shockwave Lithotripsies,Extracorporeal Shockwave Lithotripsies,Litholapaxies,Litholapaxies, Noninvasive,Litholapaxy, Noninvasive,Lithotripsies,Lithotripsies, Electrohydraulic Shockwave,Lithotripsies, Extracorporeal Shockwave,Lithotripsies, Percutaneous Ultrasonic,Lithotripsies, Ultrasonic,Lithotripsy, Electrohydraulic Shockwave,Lithotripsy, Extracorporeal Shockwave,Lithotripsy, Percutaneous Ultrasonic,Lithotripsy, Ultrasonic,Noninvasive Litholapaxies,Percutaneous Ultrasonic Lithotripsies,Shockwave Lithotripsies, Electrohydraulic,Shockwave Lithotripsies, Extracorporeal,Shockwave Lithotripsy, Electrohydraulic,Shockwave Lithotripsy, Extracorporeal,Ultrasonic Lithotripsies,Ultrasonic Lithotripsies, Percutaneous,Ultrasonic Lithotripsy, Percutaneous
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002766 Cholecystokinin A peptide, of about 33 amino acids, secreted by the upper INTESTINAL MUCOSA and also found in the central nervous system. It causes gallbladder contraction, release of pancreatic exocrine (or digestive) enzymes, and affects other gastrointestinal functions. Cholecystokinin may be the mediator of satiety. Pancreozymin,CCK-33,Cholecystokinin 33,Uropancreozymin
D002769 Cholelithiasis Presence or formation of GALLSTONES in the BILIARY TRACT, usually in the gallbladder (CHOLECYSTOLITHIASIS) or the common bile duct (CHOLEDOCHOLITHIASIS). Gallstone Disease,Cholelithiases,Gallstone Diseases
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

M Sackmann, and H Eder, and U Spengler, and J Pauletzki, and J Holl, and G Paumgartner, and T Sauerbruch
November 1994, Gastroenterology,
M Sackmann, and H Eder, and U Spengler, and J Pauletzki, and J Holl, and G Paumgartner, and T Sauerbruch
May 1996, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
M Sackmann, and H Eder, and U Spengler, and J Pauletzki, and J Holl, and G Paumgartner, and T Sauerbruch
March 1989, Gastroenterology,
M Sackmann, and H Eder, and U Spengler, and J Pauletzki, and J Holl, and G Paumgartner, and T Sauerbruch
August 1988, The New England journal of medicine,
M Sackmann, and H Eder, and U Spengler, and J Pauletzki, and J Holl, and G Paumgartner, and T Sauerbruch
June 1995, Digestive diseases and sciences,
M Sackmann, and H Eder, and U Spengler, and J Pauletzki, and J Holl, and G Paumgartner, and T Sauerbruch
July 1990, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin,
M Sackmann, and H Eder, and U Spengler, and J Pauletzki, and J Holl, and G Paumgartner, and T Sauerbruch
March 2006, Scandinavian journal of gastroenterology,
M Sackmann, and H Eder, and U Spengler, and J Pauletzki, and J Holl, and G Paumgartner, and T Sauerbruch
June 1990, Gastroenterology,
M Sackmann, and H Eder, and U Spengler, and J Pauletzki, and J Holl, and G Paumgartner, and T Sauerbruch
February 1989, The Medical letter on drugs and therapeutics,
M Sackmann, and H Eder, and U Spengler, and J Pauletzki, and J Holl, and G Paumgartner, and T Sauerbruch
September 1992, Journal of the Formosan Medical Association = Taiwan yi zhi,
Copied contents to your clipboard!